Diabetes Drugs Leads Merck’s Profit Growth for Second Quarter

Merck’s Diabetes Drugs Leads the Way in Q2 Business to benefit from world-wide epidemic   Drug maker Merck beat estimates because sales of its diabetes drugs  Januvia and Janumet.  Given the world-wide growth in type 2 diabetes, no one should be surprised that  diabetes drugs could be so successful and have a such a bright […]